HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 242 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,691,737 | -10.2% | 155,510 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $5,222,026 | -2.7% | 155,510 | -6.4% | 0.00% | 0.0% |
| Q4 2023 | $5,365,256 | +11.9% | 166,107 | +13.6% | 0.00% | 0.0% |
| Q3 2023 | $4,793,596 | +65.4% | 146,280 | +77.6% | 0.00% | +100.0% |
| Q2 2023 | $2,898,600 | -12.5% | 82,370 | -18.8% | 0.00% | 0.0% |
| Q1 2023 | $3,312,212 | +7.7% | 101,446 | +81.7% | 0.00% | 0.0% |
| Q4 2022 | $3,075,847 | +118.1% | 55,823 | +75.3% | 0.00% | 0.0% |
| Q3 2022 | $1,410,000 | -17.8% | 31,846 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $1,716,000 | +11.5% | 35,184 | +11.2% | 0.00% | 0.0% |
| Q1 2022 | $1,539,000 | +13.0% | 31,635 | -0.9% | 0.00% | – |
| Q4 2021 | $1,362,000 | +282.6% | 31,934 | +243.4% | 0.00% | – |
| Q3 2021 | $356,000 | -14.2% | 9,300 | -36.7% | 0.00% | – |
| Q2 2021 | $415,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |